AR042039A1 - Isomeros posicionales del ifn peg alfa 2 a - Google Patents
Isomeros posicionales del ifn peg alfa 2 aInfo
- Publication number
- AR042039A1 AR042039A1 ARP030104175A ARP030104175A AR042039A1 AR 042039 A1 AR042039 A1 AR 042039A1 AR P030104175 A ARP030104175 A AR P030104175A AR P030104175 A ARP030104175 A AR P030104175A AR 042039 A1 AR042039 A1 AR 042039A1
- Authority
- AR
- Argentina
- Prior art keywords
- peg
- lys
- alfa
- positional isomers
- ifn
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Isómero posicionales del interferón alfa 2S monopegilado, con un método para su aislamiento y para su uso en la fabricación de medicamentos para el tratamiento de enfermedades, especialmente para el tratamiento de enfermedades virales. Reivindicación 1:Los isómeros posicionales del interferón alfa 2S pegilado seleccionados del grupo PEG-Lys(31), PEG-Lys(49), PEG-Lys(83), PEG-Lys(112), PEG-Lys(121), PEG-Lys(131), PEG-Lys(134) y PEG-Lys(164).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02025585 | 2002-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR042039A1 true AR042039A1 (es) | 2005-06-08 |
Family
ID=32319537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030104175A AR042039A1 (es) | 2002-11-15 | 2003-11-13 | Isomeros posicionales del ifn peg alfa 2 a |
Country Status (23)
Country | Link |
---|---|
US (1) | US20040223950A1 (es) |
EP (1) | EP1562634B1 (es) |
JP (1) | JP4279258B2 (es) |
KR (1) | KR20050065677A (es) |
CN (1) | CN1323722C (es) |
AR (1) | AR042039A1 (es) |
AT (1) | ATE337017T1 (es) |
AU (1) | AU2003293668A1 (es) |
BR (1) | BR0316227A (es) |
CA (1) | CA2503594C (es) |
DE (1) | DE60307881T2 (es) |
ES (1) | ES2270152T3 (es) |
GT (1) | GT200300244A (es) |
MX (1) | MXPA05005178A (es) |
NO (1) | NO20052310L (es) |
PA (1) | PA8587801A1 (es) |
PE (1) | PE20040834A1 (es) |
PL (1) | PL376883A1 (es) |
RU (1) | RU2005118752A (es) |
TW (1) | TW200413404A (es) |
UY (1) | UY28080A1 (es) |
WO (1) | WO2004045648A1 (es) |
ZA (1) | ZA200503756B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
CA2504267A1 (en) * | 2002-11-18 | 2004-06-03 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
AU2008201682B2 (en) * | 2004-02-02 | 2011-02-24 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
AU2005211385B2 (en) | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
MXPA06013412A (es) | 2004-05-19 | 2007-01-23 | Maxygen Inc | Polipeptidos de interferon-alfa y conjugados. |
JP2008545393A (ja) | 2005-05-18 | 2008-12-18 | マキシジェン, インコーポレイテッド | 進歩したインターフェロンαポリペプチド |
US7695710B2 (en) | 2005-06-20 | 2010-04-13 | Pepgen Corporation | Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs |
EP1901777A2 (en) * | 2005-06-20 | 2008-03-26 | Pepgen Corporation | Low-toxicity, long-circulating chimeras of human interferon-alpha analogs and interferon tau |
CN101002944B (zh) * | 2006-01-17 | 2012-07-25 | 中国科学院过程工程研究所 | 支链聚乙二醇-干扰素结合物及其制备方法 |
AR078117A1 (es) * | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
ES2382124T3 (es) * | 2007-09-04 | 2012-06-05 | Biosteed Gene Expression Tech. Co., Ltd. | Interferón alfa 2b modificado con polietilenglicol y método de preparación y aplicaciones de este |
DK2196475T3 (da) * | 2007-09-04 | 2012-09-17 | Biosteed Gene Expression Tech Co Ltd | Interferon alfa 2a, som er modificeret med polyethylenglycol, fremgangsmåde til syntese deraf samt anvendelse deraf |
MX2010010953A (es) | 2008-04-03 | 2011-04-21 | Biosteed Gene Expression Tech Co Ltd | Hormona de crecimiento modificada con glicol de polietileno de doble cadena, metodo de preparacion y aplicación del a misma. |
US9272048B2 (en) | 2008-04-29 | 2016-03-01 | Ascendis Pharma Growth Disorders Division A/S | PEGylated recombinant human growth hormone compounds |
EP2113256A1 (en) | 2008-04-29 | 2009-11-04 | Ascendis Pharma AS | PEGylated rhGH compounds |
DE102009009344B4 (de) * | 2009-02-05 | 2018-01-04 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Verfahren und Anordnung zur Reinigung des Reaktionsgemisches bei der Herstellung von Radiopharmaka |
WO2010110503A1 (ko) * | 2009-03-27 | 2010-09-30 | 주식회사 중외제약 | 인터페론-알파 및 세포질 잔류성 세포막 투과 펩타이드를 포함하는 IFN-α 융합 단백질 |
CN101514229B (zh) * | 2009-04-03 | 2012-05-09 | 海南四环心脑血管药物研究院有限公司 | 人干扰素α衍生物及其聚乙二醇化修饰物 |
CN106749608B (zh) * | 2015-11-18 | 2021-10-15 | 石药集团中奇制药技术(石家庄)有限公司 | 干扰素α缀合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5951974A (en) * | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
JP2006508918A (ja) * | 2002-09-05 | 2006-03-16 | ザ ジェネラル ホスピタル コーポレーション | 修飾されたアシアロインターフェロンおよびその使用 |
-
2003
- 2003-11-10 AU AU2003293668A patent/AU2003293668A1/en not_active Abandoned
- 2003-11-10 RU RU2005118752/04A patent/RU2005118752A/ru not_active Application Discontinuation
- 2003-11-10 MX MXPA05005178A patent/MXPA05005178A/es unknown
- 2003-11-10 ES ES03789020T patent/ES2270152T3/es not_active Expired - Lifetime
- 2003-11-10 BR BR0316227-3A patent/BR0316227A/pt not_active Application Discontinuation
- 2003-11-10 WO PCT/EP2003/012498 patent/WO2004045648A1/en active IP Right Grant
- 2003-11-10 JP JP2004552547A patent/JP4279258B2/ja not_active Expired - Lifetime
- 2003-11-10 PL PL376883A patent/PL376883A1/pl not_active Application Discontinuation
- 2003-11-10 CN CNB2003801033411A patent/CN1323722C/zh not_active Expired - Lifetime
- 2003-11-10 DE DE60307881T patent/DE60307881T2/de not_active Expired - Lifetime
- 2003-11-10 CA CA2503594A patent/CA2503594C/en not_active Expired - Fee Related
- 2003-11-10 KR KR1020057008685A patent/KR20050065677A/ko not_active Application Discontinuation
- 2003-11-10 EP EP03789020A patent/EP1562634B1/en not_active Expired - Lifetime
- 2003-11-10 AT AT03789020T patent/ATE337017T1/de not_active IP Right Cessation
- 2003-11-12 PA PA20038587801A patent/PA8587801A1/es unknown
- 2003-11-12 TW TW092131686A patent/TW200413404A/zh unknown
- 2003-11-13 AR ARP030104175A patent/AR042039A1/es unknown
- 2003-11-13 UY UY28080A patent/UY28080A1/es not_active Application Discontinuation
- 2003-11-13 PE PE2003001148A patent/PE20040834A1/es not_active Application Discontinuation
- 2003-11-13 GT GT200300244A patent/GT200300244A/es unknown
- 2003-11-13 US US10/712,494 patent/US20040223950A1/en not_active Abandoned
-
2005
- 2005-05-10 ZA ZA200503756A patent/ZA200503756B/xx unknown
- 2005-05-11 NO NO20052310A patent/NO20052310L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE60307881T2 (de) | 2007-03-08 |
US20040223950A1 (en) | 2004-11-11 |
PA8587801A1 (es) | 2004-09-16 |
CA2503594A1 (en) | 2004-06-03 |
ATE337017T1 (de) | 2006-09-15 |
NO20052310D0 (no) | 2005-05-11 |
CN1323722C (zh) | 2007-07-04 |
EP1562634A1 (en) | 2005-08-17 |
JP4279258B2 (ja) | 2009-06-17 |
UY28080A1 (es) | 2004-05-31 |
CN1711109A (zh) | 2005-12-21 |
BR0316227A (pt) | 2005-10-04 |
PL376883A1 (pl) | 2006-01-09 |
MXPA05005178A (es) | 2005-07-22 |
TW200413404A (en) | 2004-08-01 |
DE60307881D1 (de) | 2006-10-05 |
ES2270152T3 (es) | 2007-04-01 |
CA2503594C (en) | 2011-05-10 |
GT200300244A (es) | 2004-06-03 |
NO20052310L (no) | 2005-08-09 |
AU2003293668A1 (en) | 2004-06-15 |
WO2004045648A1 (en) | 2004-06-03 |
EP1562634B1 (en) | 2006-08-23 |
KR20050065677A (ko) | 2005-06-29 |
ZA200503756B (en) | 2008-02-27 |
JP2006515571A (ja) | 2006-06-01 |
PE20040834A1 (es) | 2004-11-17 |
RU2005118752A (ru) | 2006-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR042039A1 (es) | Isomeros posicionales del ifn peg alfa 2 a | |
DE60311272D1 (de) | Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten | |
UY27720A1 (es) | Aroilpiridinonas monocíclicas, | |
AR037109A1 (es) | Uso de flibanserina | |
ECSP034438A (es) | Nuevos peptidos como inhibidores de ns-3-serina proteasa del virus de la hepatitis c | |
ECSP045491A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
AR022578A1 (es) | Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial | |
DK1025124T3 (da) | Human interferon-alfa-analoge med lav toksicitet | |
BR0201290A (pt) | Bola para jogo de basquete e método de construir a mesma | |
BR0306931A (pt) | Peptìdeos como inibidores de protease serina-ns3 do vìrus da hepatite c | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
UY26370A1 (es) | "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación". | |
UY27455A1 (es) | Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos. | |
HRP20050024A2 (en) | Pegylated t20 polypeptide | |
NO20034878D0 (no) | Antivirale forbindelser | |
UY27244A1 (es) | Uso del acido- (4´-trifluormetilfenil) - amida (z) -2- ciano-3- hidroxi-but-2-enoico para el tratamiento de la esclerosis multiple | |
BR0107963A (pt) | Dicarbamatos de dietiloctanodiol e dialofanatos de dietiloctanodiol, sua preparação e uso | |
BR0315836A (pt) | Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação | |
ECSP034872A (es) | Nuevos heterociclos 3 | |
AR021576A1 (es) | Analogos del peptido 1-similar al glucagon, uso de los mismos para la manufactura de un medicamento y composiciones farmaceuticas que los contienen. | |
ES2188232T3 (es) | Uso de cetirizina para impedir la aparicion del asma. | |
EA200600682A1 (ru) | Сополимеры 1-винилпирролидин-2-она/сложного эфира | |
BRPI0406985A (pt) | Terapia de combinação de hcv | |
ES2140329B1 (es) | Utilizacion de acido maslinico como inhibidor de proteasas para el tratamiento de la enfermedad causada por los virus de la inmunodeficiencia adquirida. | |
ES1002588Y (es) | Zapato deportivo, en particular para el baloncesto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |